Sotac Pharmaceuticals (SOTAC) Shareholding Pattern

NSE: SOTAC • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 72.85%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 5.13%
Total Shareholders 240
As of Sept 2025
View the latest shareholding pattern of Sotac Pharmaceuticals (SOTAC) including promoter, FII, DII, and public holdings. Track SOTAC ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See SOTAC cash flow statement)

Sotac Pharmaceuticals (SOTAC) Shareholding Summary

  • Promoter holding remains unchanged at 72.85% in Sept 2025
  • FII/FPI holding remains unchanged at 0.00% in Sept 2025
  • DII holding remains unchanged at 0.00% in Sept 2025
  • Public holding has increased from 4.70% to 5.13% in Sept 2025
  • Number of shareholders decreased from 243 to 240 in Sept 2025

SOTAC Quarterly Ownership Changes

Quarter-over-quarter changes for Sotac Pharmaceuticals from Mar 2025 to Sept 2025.

Promoter Holding Change
Mar 2025 to Sept 2025
No Change
FII Holding Change
Mar 2025 to Sept 2025
No Change
DII Holding Change
Mar 2025 to Sept 2025
No Change
Public Holding Change
Mar 2025 to Sept 2025
+0.43%

Sotac Pharmaceuticals (SOTAC) Quarterly Shareholding Trends

Visual breakdown of SOTAC ownership distribution over time. Learn more about SOTAC quarterly performance.

Promoter
FII
DII
Public
Government

Rising institutional holdings in SOTAC often correlate with improved fundamentals. Check out SOTAC share price charts.

Sotac Pharmaceuticals (SOTAC) Shareholding Data

Download complete SOTAC ownership data for offline analysis. Discover SOTAC value investing.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 72.85% 0.00% 0.00% 0.00% 5.13% 22.02% 100.00% 240
Mar 2025 72.85% 0.00% 0.00% 0.00% 4.70% 22.45% 100.00% 243
Sept 2024 72.85% 0.00% 0.00% 0.00% 6.01% 21.14% 100.00% 251
Mar 2024 72.85% 0.00% 0.00% 0.00% 5.82% 21.33% 100.00% 245
Sept 2023 72.85% 0.00% 0.00% 0.00% 5.32% 21.83% 100.00% 255
Apr 2023 72.85% 0.00% 0.00% 0.00% 8.19% 18.96% 100.00% 784

SOTAC promoter holding above 50% indicates strong insider confidence. Explore the Sotac Pharmaceuticals networth for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 72.85% 0.00% 0.00% 0.00% 5.13% 22.02% 100.00% 240
Mar 2025 72.85% 0.00% 0.00% 0.00% 4.70% 22.45% 100.00% 243
Sept 2024 72.85% 0.00% 0.00% 0.00% 6.01% 21.14% 100.00% 251
Mar 2024 72.85% 0.00% 0.00% 0.00% 5.82% 21.33% 100.00% 245
Sept 2023 72.85% 0.00% 0.00% 0.00% 5.32% 21.83% 100.00% 255
Apr 2023 72.85% 0.00% 0.00% 0.00% 8.19% 18.96% 100.00% 784

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 72.85% 0.00% 0.00% 0.00% 4.70% 22.45% 100.00% 243
Mar 2024 72.85% 0.00% 0.00% 0.00% 5.82% 21.33% 100.00% 245

Year-over-year trends reveal long-term ownership shifts.

Understanding Sotac Pharmaceuticals (SOTAC) Shareholding Pattern

Sotac Pharmaceuticals shareholding pattern reveals who owns SOTAC stock and how ownership changes over time. High promoter stakes in SOTAC often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your SOTAC trades. Sotac Pharmaceuticals dividend policy

Combine SOTAC ownership analysis with price movements and financial performance for a complete investment picture. (See SOTAC 52-week high low)